Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
70.03
+1.83 (2.68%)
Oct 26, 2026, 4:00 PM EDT - Market closed

Tarsus Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Tarsus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $99.56. The average 1-year stock price forecast is 42.17% higher than the current stock price, while the lowest is $84 (+19.95%) and the highest is $116 (+65.64%).

Price Target: $99.56 (+42.17%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$84$99.56$100$116
Change+19.95%+42.17%+42.80%+65.64%

Analyst Ratings

The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy888799
Buy111011
Hold000000
Sell000000
Strong Sell000000
Total99971010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
$84
BuyMaintains$84+19.95%Oct 12, 2026
Barclays
Barclays
Buy
Reiterates
$110
BuyReiterates$110+57.08%Oct 9, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$100
BuyMaintains$100+42.80%Oct 2, 2026
Goldman Sachs
Goldman Sachs
Buy
Initiates
$116
BuyInitiates$116+65.64%Sep 24, 2026
Jefferies
Jefferies
Buy
Reiterates
$105
BuyReiterates$105+49.94%Sep 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
736.88M
from 451.36M
Increased by 63.26%
Revenue Next Year
920.04M
from 736.88M
Increased by 24.86%
EPS This Year
-5.79
from -1.59
EPS Next Year
-0.50
from -5.79
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
57.03M25.82M17.45M182.95M451.36M736.88M
Revenue Growth
--54.73%-32.42%948.62%146.71%63.26%
Operating Income
-12.16M-62.71M-143.16M-120.57M-70.97M-318.88M
Net Income
-13.83M-62.09M-135.89M-115.55M-66.42M-318.99M
EPS
-----1.59-5.79
Free Cash Flow
-----22.31M-114.61M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High753.7M
Avg736.9M
Low722.4M

Revenue Growth

Revenue Growth202620272028
High
67.0%
Avg
63.3%
Low
60.0%

EPS Forecast

EPS202620272028
High-2.52
Avg-5.79
Low-11.63

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-